Stevia First Corp. (OTCBB: STVF) reached up 27.19% in morning trading to $1.45 with 1M shares traded. Stevia First Corp. is seeking to establish a vertically-integrated stevia enterprise in the U.S. with expertise in stevia seed and tissue propagation, plant breeding, and cultivation. Stevia First's U.S. operations are located in the heart of California's Central Valley, one of the world's most productive agricultural regions. Stevia First Corp. (OTC.BB: STVF.OB - News) announce Monday the appointment of Dr. Anthony E. Maida, III, Ph.D., MA, MBA, to the Board of Directors.
PeopleString Corporation (OTCBB: PLPE) reached up 31.75% in morning trading to $.083 with 350K shares traded. PeopleString Corporation creates technologies that empower consumers to leverage their social networks to capitalize on the best national and local deals. PeopleString's patent pending "Share It Up" technology harnesses the power of social media to create coupons that go up in value when shared and rewards loyal customers who share their favorite merchants with others. PeopleString also offers patent pending "Insta Portal" technology which allows users to import pieces of their favorite websites into their own PeopleString homepage. PeopleString Corporation (OTCBB: PLPE.OB - News) today announced that it has launched a new 30 and 60 second television advertising campaign for its PeopleString social network and portal.
Talon Therapeutics, Inc. (OTCBB:TLON) reached up 20.95% in morning trading to $.895 with 450K shares traded. Talon Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. Talon is developing its lead product candidate, Marqibo, primarily for the treatment of acute lymphoblastic leukemia and lymphomas. The Company has additional pipeline opportunities some of which, like Marqibo, are designed to improve delivery and enhance the therapeutic benefits of well characterized, proven chemotherapies and enable high potency dosing without increased toxicity. Talon Therapeutics, Inc. (OTCBB:TLON.OB - News) yesterday annnounced they will host a conference call on Thursday, March 22, 2012 at 9:00AM PT, to discuss the outcome of the Oncologic Drugs Advisory Committee (ODAC) Meeting on Marqibo.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
